CING

Cingulate Inc.

NasdaqCMUSDEQUITY DELAYED

5.50

▲ 0.17 (3.21%)

MARKET · —

Price

Open

5.33

Prev close

5.33

Day high

5.55

Day low

5.18

Volume

226.25K

Market cap

—

P/E (TTM)

—

52W range

3.16 – 11.89

Trailing performance

Price return · vs SPY

Returnvs SPY

+9.04% +10.4%

+14.67% +10.9%

+17.09% +14.0%

-5.77% -16.8%

YTD

+27.88% +15.6%

+42.31% +22.3%

-96.40% -170.6%

— —

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Fundamentals

TTM · reported

Market cap—

Enterprise value—

Revenue (TTM)—

Gross profit—

EBITDA—

Net income—

EPS (TTM)—

Free cash flow—

Total cash—

Total debt—

Book value / share—

Shares outstanding—

Float—

Short % of float—

Dividend yield—

Beta (5Y)—

Valuation & profitability ratios

Account required

Trailing P/E—

Forward P/E—

PEG ratio—

Price / sales—

Price / book—

EV / revenue—

EV / EBITDA—

Gross margin—

Operating margin—

Profit margin—

Return on equity—

Return on assets—

Debt / equity—

Current ratio—

Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Create free account Sign in

Analyst targets & ownership

Account required

Mean target—

High target—

Low target—

Implied upside—

Analyst count—

Consensus—

Strong buy / Buy— / —

Hold—

Sell / Strong sell— / —

Held by insiders—

Held by institutions—

Institutions holding—

Free account required

Price targets, consensus spread, insider and institutional ownership.

Create free account Sign in

Moving averages & technicals

Computed from 2Y daily closes

SMA 10

5.23

+5.18% from price

SMA 20

5.02

+10.46% from price

SMA 50

4.97

+11.76% from price

SMA 100

5.02

+9.50% from price

SMA 200

5.19

+6.85% from price

EMA 12

5.21

+5.68% from price

EMA 26

5.06

+8.62% from price

EMA 50

5.02

+9.68% from price

RSI (14)

66.6

Neutral

MACD (12,26,9)

0.14

Hist 0.05

ATR (14)

0.28

4.99% of price

Realised vol 30D

41.8%

Annualised

Bollinger upper

5.60

20, 2σ

Bollinger lower

4.45

20, 2σ

50 / 200 cross

Death

4.97 vs 5.19

Trend bias

Above 200

+6.85%

Risk profile

Daily returns · 1Y window

Beta vs SPY

1.43

More volatile than market

Correlation to SPY

0.21

Largely independent

Realised vol 30D

41.8%

Annualised

Market vol 1Y

12.9%

SPY, annualised

Max drawdown 1Y

-69.1%

Peak to trough

Max drawdown 5Y

-99.8%

Peak to trough

ATR 14

0.28

4.99% of price

Beta (reported)

—

5Y monthly, from filing

Options chain

Account required

ExpirySpot 5.50

Calls

Strike	Last	Bid	Ask	Vol	OI	IV
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%

Puts

Strike	Last	Bid	Ask	Vol	OI	IV
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%

Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Create free account Sign in

Headlines

CING · links out to the publisher

CING: Second Quarter Results Zacks Small Cap Research · 3d ago Cingulate Inc. Reports Second Quarter 2026 Financial Results and Provides Update on CTx-1301 CMC Progress Towards NDA Resubmission and Commercial Readiness GlobeNewswire · 9d ago Cingulate Publishes Peer-Reviewed Data Demonstrating CTx-1301’s Differentiated Pharmacokinetic Profile GlobeNewswire · 11d ago Cingulate Announces Publication of Phase 3 ADHD Trial Results in Journal of Child and Adolescent Psychopharmacology GlobeNewswire · 23d ago Cingulate Inc. (NASDAQ: CING) Added to Russell 3000E® GlobeNewswire · 51d ago Cingulate Issued First U.S. Patent for Lead ADHD Asset CTx-1301 GlobeNewswire · 67d ago Stonegate Capital Partners Updates Coverage on Cingulate Inc. (CING) 1Q26 TMX Newsfile · 79d ago Cingulate Receives Complete Response Letter from FDA for CTx-1301 GlobeNewswire · 81d ago

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.